Volume 12, Issue 3 (9-2024)                   JoMMID 2024, 12(3): 217-223 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghafouri H, Mashayekhi P, Davoudi M. Control of Opportunistic Oral Cavity Infections Using Postbiotics Secreted by Aerobic Oral Flora, with Minimal Impact on Host Cells. JoMMID 2024; 12 (3) :217-223
URL: http://jommid.pasteur.ac.ir/article-1-687-en.html
Control of Opportunistic Oral Cavity Infections Using Postbiotics Secreted by Aerobic Oral Flora, with Minimal Impact on Host Cells
Haranoosh Ghafouri , Parnian Mashayekhi , Maryam Davoudi *
Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (135 Views)
Introduction: Postbiotics derived from the natural oral microbiome offer a potential solution for chemotherapy-induced oral dysbiosis by restoring microbial balance. These compounds hold promise for managing oral infections, particularly in vulnerable populations, by restoring microbial balance, directly inhibiting pathogen growth, and promoting a healthy mucosal immune response. This study evaluates the antimicrobial activity of postbiotics derived from aerobic oral bacteria against Staphylococcus aureus and assesses their cytotoxicity in human cells, contributing to the development of new therapeutic strategies for oral infections. Methods: Specific strains of aerobic oral bacteria were isolated and cultured in nutrient broth at 37°C in a 5% CO2 atmosphere. After 24 h of incubation, the supernatant containing postbiotics was collected and centrifuged, followed by filtration to isolate the postbiotics. The antibacterial activity of these postbiotics was assessed against S. aureus isolated from oral wounds using the agar well diffusion method on Mueller-Hinton agar plates. In parallel, the cytotoxic effects on Normal Human Dermal Fibroblasts (NHDF) were evaluated through MTT viability assays to measure metabolic activity, and SYBR Green staining to quantify DNA content, and assess cell membrane integrity. Statistical analysis was performed using one-way ANOVA followed by Tukey's post-hoc test, with significance set at P < 0.05. Results: Postbiotics exhibited significant antimicrobial activity against S. aureus, as evidenced by a mean zone of inhibition of 17.0 mm (±1.4 mm), while no inhibition was observed in saline controls. Furthermore, postbiotics treatment resulted in NHDF cell viability of 94% (±1.6%) compared to the untreated controls 75.2% (±0.7%); P < 0.0001, demonstrating their biocompatibility. Conclusion: This study demonstrates the promising therapeutic potential of postbiotics for combating opportunistic oral infections, exhibiting negligible cytotoxicity towards host cells. Future research will explore isolating and identifying the active components of these postbiotics and evaluating their efficacy in vivo models and human oral cell lines.
Keywords: Postbiotics, Opportunistic infections, Oral microbiome, Oral cavity, Staphylococcus aureus, Agar well diffusion, MTT assay, SYBR green staining
Full-Text [PDF 1042 kb]   (57 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2024/09/29 | Accepted: 2024/09/11 | Published: 2024/12/22
References
1. Da Silva R, Casella T. Healthcare-associated infections in patients who are immunosuppressed due to chemotherapy treatment: a narrative review. J Infect Dev Ctries. 2022; 16 (12): 1784-95. [DOI:10.3855/jidc.16495] [PMID]
2. José RJ, Periselneris JN, Brown JS. Opportunistic bacterial, viral and fungal infections of the lung. Medicine. 2020; 48 (6): 366-72. [DOI:10.1016/j.mpmed.2020.03.006] [PMID] [PMCID]
3. Senpuku H, Yoshimura K, Takai H, Maruoka Y, Yamashita E, Tominaga A, et al. Role of Macrophage Colony-Stimulating Factor for Staphylococcal Infection in the Oral Cavity. J Clin Med. 2023; 12 (18): 5825. [DOI:10.3390/jcm12185825] [PMID] [PMCID]
4. Singh V, Singh AK. Oral mucositis. Natl J Maxillofac Surg. 2020; 11 (2): 159-68. [DOI:10.4103/njms.NJMS_10_20] [PMID] [PMCID]
5. Sedghizadeh PP, Mahabady S, Allen CM. Dent Clin North Am. 2017; 61 (2): 389-400. [DOI:10.1016/j.cden.2016.12.007] [PMID] [PMCID]
6. Hafner D, Hrast P, Tomaževič T, Jazbec J, Kavčič M. Photobiomodulation for chemotherapy-induced oral mucositis in pediatric patients. Biomolecules. 2023; 13 (3): 418. [DOI:10.3390/biom13030418] [PMID] [PMCID]
7. de Azevedo Seara MFM. Sustainable Production of Postbiotics for Food Applications. Appl Sci. 2023; 13 (6): 3391. [DOI:10.3390/app13063391]
8. Homayouni Rad A, Pourjafar H, Mirzakhani E. A comprehensive review of the application of probiotics and postbiotics in oral health. Front Cell Infect Microbiol. 2023; 13: 1120995. [DOI:10.3389/fcimb.2023.1120995] [PMID] [PMCID]
9. Rafique N, Jan SY, Dar AH, Dash KK, Sarkar A, Shams R, et al. Promising bioactivities of postbiotics: A comprehensive review. J Agric Food Res. 2023; 14: 100708. [DOI:10.1016/j.jafr.2023.100708]
10. Felder M, Kapur A, Gonzalez-Bosquet J, Horibata S, Heintz J, Albrecht R, et al. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Mol Cancer. 2014; 13: 129. [DOI:10.1186/1476-4598-13-129] [PMID] [PMCID]
11. Kocot AM, Jarocka-Cyrta E, Drabińska N. Overview of the importance of biotics in gut barrier integrity. Int J Mol Sci. 2022; 23 (5): 2896. [DOI:10.3390/ijms23052896] [PMID] [PMCID]
12. Dhanisha SS, Guruvayoorappan C. Pathological implications of mucin Signaling in Metastasis. Curr Cancer Drug Targets. 2023; 23 (8): 585-602. [DOI:10.2174/1568009623666230320121332] [PMID]
13. van Putten JPM, Strijbis K. Transmembrane mucins: signaling receptors at the intersection of inflammation and cancer. J Innate Immun. 2017; 9 (3): 281-99. [DOI:10.1159/000453594] [PMID] [PMCID]
14. Hambire C, Hambire U. Evaluation of effect of consumption of probiotics on the gingival and periodontal health status in children undergoing chemotherapy. Indian J Cancer. 2023; 60 (3): 373-8. [DOI:10.4103/ijc.IJC_215_20] [PMID]
15. Khani N, Shkouhian Smj, Kafil HS, Gilani N, Abbasi A, Rad AH. Assessing the growth-inhibitory activity of postbiotics of Lactobacillus spp. against Staphylococcus aureus under in vitro circumstances and food model. Lett Appl Microbiol. 2023; 76 (2): ovac056. [DOI:10.1093/lambio/ovac056] [PMID]
16. Zhao Z, Wu J, Sun Z, Fan J, Liu F, Zhao W, et al. Postbiotics derived from L. paracasei ET-22 inhibit the formation of S. mutans biofilms and bioactive substances: An analysis. Molecules. 2023; 28 (3): 1236. [DOI:10.3390/molecules28031236] [PMID] [PMCID]
17. Wu H, Guang C, Zhang W, Mu W. Recent development of phenyllactic acid: physicochemical properties, biotechnological production strategies and applications. Crit Rev Biotechnol. 2023; 43 (2): 293-308. [DOI:10.1080/07388551.2021.2010645] [PMID]
18. Das S, Majhi PD, Al-Mugotir MH, Rachagani S, Sorgen P, Batra SK. Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifyingGolgi/post-Golgi compartments. Sci Rep. 2015; 5 (1): 9759. [DOI:10.1038/srep09759] [PMID] [PMCID]
19. Gipson IK, Spurr-Michaud S, Tisdale A, Menon BB. Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function. PloS One. 2014; 9 (6): e100393. [DOI:10.1371/journal.pone.0100393] [PMID] [PMCID]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.